- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Arqule Inc+ Add to Watchlist
ARQL:US2.7100 USD 0.0700 2.52%
As of 20:10:00 ET on 05/22/2013.
Company Profile for Arqule Inc (ARQL)
ArQule Inc. develops cancer therapeutics based on its proprietary Activated Checkpoint Therapy platform. The Company's platform is designed to produce small molecule compounds that selectively kill cancer cells while leaving normal cells unharmed. ArQule's products are intended to be effective against multiple types of cancer.
Key Executives for Arqule Inc (ARQL)
|Paolo PucciChief Executive Officer||Peter S LawrencePresident/COO/Secy/Gen Cnsl|
|Brian SchwartzSenior VP/Chief Medical Ofcr||Thomas C K ChanSenior VP/Chf Scientific Ofcr|
|William B BoniVP:Investor Relations|